Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01655589
What this trial is testing

VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents

Who this might be right for
Macular Degeneration
Institute of Vision, Brasil 74
Not applicableStudy completedNCT00549055
What this trial is testing

A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

Who this might be right for
Neovascular Age-related Macular Degeneration
Pfizer 38
Large-scale testing (Phase 3)Study completedNCT00090623
What this trial is testing

RhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Genentech, Inc. 180
Not applicableStudy completedNCT04642183
What this trial is testing

Single In-Clinic Encounter With the Notal Vision Home OCT

Who this might be right for
Neovascular Age-related Macular DegenerationIntermediate Age Related Macular Degeneration (Disorder)
Notal Vision Inc. 70
Post-approval studies (Phase 4)UnknownNCT03056079
What this trial is testing

Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept

Who this might be right for
Age Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion+1 more
Unity Health Toronto 168
Testing effectiveness (Phase 2)Study completedNCT02302989
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Leonard Feiner, MD, PhD 4
Early research (Phase 1)Study completedNCT01154062
What this trial is testing

Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
GlaxoSmithKline 15
Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210
Early research (Phase 1)Study completedNCT00383370
What this trial is testing

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

Who this might be right for
Neovascular Age Related Macular Degeneration
Regeneron Pharmaceuticals 20
Not applicableNot Yet RecruitingNCT06022744
What this trial is testing

An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD

Who this might be right for
To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550011
What this trial is testing

Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Neovascular (Wet) AMD
Avirmax Biopharma Inc 18
Early research (Phase 1)Study completedNCT02461771
What this trial is testing

Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Apellis Pharmaceuticals, Inc. 13
Large-scale testing (Phase 3)Ended earlyNCT04757610
What this trial is testing

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 986
Not applicableUnknownNCT03838679
What this trial is testing

Imaging of the Angiofibrotic Switch in Neovascular AMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Medical University of Vienna 120
Large-scale testing (Phase 3)UnknownNCT00559715
What this trial is testing

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Who this might be right for
Age-Related Neovascular Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 366
Large-scale testing (Phase 3)Not Yet RecruitingNCT07489586
What this trial is testing

A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Qilu Pharmaceutical Co., Ltd. 356
Testing effectiveness (Phase 2)Ended earlyNCT02418754
What this trial is testing

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 505
Testing effectiveness (Phase 2)Study completedNCT02118831
What this trial is testing

Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

Who this might be right for
Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
California Retina Consultants 56
Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Testing effectiveness (Phase 2)UnknownNCT02599064
What this trial is testing

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Who this might be right for
Age-related Macular DegenerationSubfoveal Choroidal NeovascularizationSubretinal Scarring+1 more
RXi Pharmaceuticals, Corp. 9
Next Page